← Leaderboards
Rajiv Radhakrishnan
Yale University
$2,470,718
Attributed
$4,418,790
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2018–24$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,418,790 · 6
By mechanism
R01$2,288,996 · 1
R21$2,129,794 · 5
Top collaborators
- Deepak Cyril D'Souza6 shared
- Mohini Ranganathan4 shared
- Taeho Gregory Rhee2 shared
- Samuel Wilkinson2 shared
Most similar at Yale University
Same institution · by research overlap
- Mohini Ranganathan$2,625,379
- Lisa M Monteggia$14,033,132
- Min Wang$7,212,072
- Mary M Torregrossa$10,550,672
- Yiyun Henry Huang$18,008,787
Others in their field
Other Emerging Leaders on “Brain”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Susan Abushakra · Alzheon, Inc.$50,765,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Evan Z Macosko · Broad Institute, Inc.$36,871,464
- Greg Yothers · University Of Chicago$35,003,821
- Anthony Philippakis · University Of California Santa Cruz$30,961,549
Research focus
BrainPositron-Emission TomographyIn VivoSpecificityCannabisLigandsBindingReportingAnimalsProteinsChronicMolecularIndexingCannabinoidsBrain RegionDensityBiologicalBrain ImagingMedicalDrug UsageMarijuana UseMarijuana Use DisorderAgonistLegal
Grant awards (15)
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?$597,469
R01 · FY2024 · DA
Impact of cannabis legalization on prescription drug use and health outcomes in Connecticut$208,330
R21 · FY2024 · DA · contact PI
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?$586,734
R01 · FY2023 · DA
Impact of cannabis legalization on prescription drug use and health outcomes in Connecticut$267,110
R21 · FY2023 · DA · contact PI
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)$51,979
R21 · FY2023 · AT · contact PI
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?$579,972
R01 · FY2022 · DA
Preliminary studies of muscarinic M1 receptor availability and cognition in schizophrenia$209,375
R21 · FY2022 · MH · contact PI
Effect of Cannabis Use on Synaptic Density in Older Adults$209,375
R21 · FY2022 · DA · contact PI
Do hippocampal synaptic density deficits in cannabis use disorder improve following abstinence?$524,821
R01 · FY2021 · DA
Preliminary studies of muscarinic M1 receptor availability and cognition in schizophrenia$251,250
R21 · FY2021 · MH · contact PI
Effect of Cannabis Use on Synaptic Density in Older Adults$251,250
R21 · FY2021 · DA · contact PI
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization$221,251
R21 · FY2020 · AT · contact PI
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization$209,375
R21 · FY2020 · AT · contact PI
Effect of Cannabidiol on Microglial Activation and Central Pain-Sensitization$29,999
R21 · FY2019 · AT · contact PI
Imaging Complement Component 4 Gene Effects on Human Synaptic Density in Vivo Using 11C-UCB-J PET$220,500
R21 · FY2018 · MH · contact PI